An official website of the United States government
Here's how you know
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more:
PMC Disclaimer
|
PMC Copyright Notice
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
In the article by Zambon et al.,1 the original version of Figure 1 showed the age at attaining developmental milestones in 24 patients with LAMA2‐RD. Tick marks on vertical axis indicated single patients. Patients with more severe phenotype/complete merosin deficiency (CD) were included in the bottom section; patients with milder phenotype/partial deficiency (PD) were in the top section. Dots indicated age at independent sitting, squares age at walking with support, and triangles age at independent walking. For two patients with PD, it squares were wrongly assigned instead of triangles. In the main text, it is correctly indicated that both these patients achieved independent ambulation (red triangles). The corrected figure follows.
Reference
1.
Zambon AA, Ridout D, Main M, et al. LAMA2‐related muscular dystrophy: natural history of a large pediatric cohort. Ann Clin Transl Neurol
2020;7:1870–1882. 10.1002/acn3.51172
[DOI] [PMC free article] [PubMed] [Google Scholar]